Drug Database
Back to search

Denmark· DK-28104731210

Hipragumboro CW

A gumboron tauti -rokote product, registered in Denmark by Laboratorios Hipra S.A.. The same ATC class is registered in 2 of our 19 countries.

ATC QI01AD09

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedHipragumboro CWATCQI01AD09REGISTER NO.DK-28104731210PACKS LISTED1CHECKEDSeptember 30, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about HipragumboroAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Hipragumboro is registered in 2 of 19 countries.

Countries holding a registration under ATC QI01AD09 (gumboron tauti -rokote), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 1 of them publish a price we can compare per daily dose
Search Hipragumboro products by name

Hipragumboro · ATC QI01AD09

2 / 19 countries

  • Denmark
  • Finlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Danish Medicines Agency (Denmark)
Manufacturer
Laboratorios Hipra S.A.
Country
Denmark (DK)
ATC code
QI01AD09
ATC class
Gumboron tauti -rokote
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28104731210

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under QI01AD09

Gumboron tauti -rokote, as other registers publish it.

All Hipragumboro products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e9332ebe-9056-441d-afd1-c3a3f2d38912
GET /v1/drugs/e9332ebe-9056-441d-afd1-c3a3f2d38912?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "lyofilisat til anvendelse i drikkevand",
  "source": "dkma",
  "strength": "7675",
  "auth_role": "CMS",
  "dk_drugid": "28104731210",
  "substance": null,
  "auth_procedure": "Decentral procedure",
  "in_medicinpriser": true,
  "registration_date_serial": "40731"
}
API referenceMCP serverPlans

See everything about Hipragumboro.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console